2018 Technology Showcase

Thank you for a great event!

If you are interested in licensing, partnering opportunities or learning more about the technologies featured at the 2018 Technology Showcase, please contact us at ncitechtransfer@mail.nih.gov.

Event Overview:

The second annual Technology Showcase on June 13, 2018 showcased technologies being developed at the NCI and Frederick National Laboratory for Cancer Research (FNLCR) to encourage startup company formation, technology licensing, and collaborations. The 2018 event brought together technology development stakeholders from across the region, and included several networking opportunities. The list of inventorsand featured technologies and posters can be found in the event agenda below; additional technologies highlighted in the Special Poster Session are also listed below.

Date and Location:

Wednesday, June 13, 2018
7:30 AM - 7:00 PM (includes post-showcase networking event)
FNLCR Advanced Technology Research Facility
8560 Progress Drive
Frederick, MD 21702

Event Highlights:

NCI Director, Dr. Norman "Ned" Sharpless keynote address on “Innovation and Commercialization: How NCI Collaborations with Industry Benefit Patients"
19 featured NCI and FNLCR technologies available for licensing and partnering
Panel discussion comprised of successful biotechnology innovators from MedImmune, MiRecule, Inc. and Veralox Therapeutics, LLC who shared their insights about NIH as a technology development partner
Opportunities to learn about how license from and collaborate with NCI and FNLCR
An interactive poster session highlighting 12 NCI technologies available for licensing and partnering presented by the NCI Technology Transfer Ambassadors Program, and an additional poster highlighting the Center for Advanced Preclinical Research (CAPR)
Opportunities to learn how to access resources available at the FNLCR
Networking opportunities

Agenda:

7:30 – 8:30 AM	Check-in / Registration
8:30 – 8:45 AM	Welcome and Introduction Ethan Dmitrovsky, M.D., President of Leidos Biomedical Research and Laboratory Director of the FNLCR Jan H. Gardner, County Executive, Frederick County, Maryland
8:45 – 9:15 AM	INTRODUCTION: Thomas Stackhouse, Ph.D., Associate Director, NCI Technology Transfer Center (TTC) KEYNOTE: Dr. Ned Sharpless, NCI Director – “Innovation and Commercialization: How NCI Collaborations with Industry Benefit Patients”
9:15 – 9:30 AM	NCI Technology Transfer Center Overview – Michael Salgaller, Ph.D., Invention Development and Marketing Supervisor, NCI TTC
9:30 – 10:45 AM	Technology Session One MODERATOR: Michael Salgaller, Ph.D., NCI TTC John Beutler, Ph.D., Molecular Targets Program, NCI, CCR – "Improved Englerin A Analogues for Kidney Cancer Therapeutics” – E-140-2017 Kandice Tanner, Ph.D., Laboratory of Cell Biology, NCI, CCR – “Optical Trap Methods to Determine the Viscoelastic Properties of Biological Materials” – E-251-2015 Nadya Tarasova, Ph.D., Cancer and Inflammation Program, NCI, CCR – "Potent Inhibitors of Non-Druggable Oncoproteins” Associated technologies: “Synthetic Lipopeptide Inhibitors of RAS Oncoproteins” E-293-2010, “Peptide Inhibitors for Viral Infections and as Anti-inflammatory Agents” E-167-2010 and "Anti-bacterial Treatments Using Peptide-Based Inhibitors of the STAT3-IL10 Pathway" E-278-2014 Kedar Narayan, Ph.D., Center for Molecular Microscopy, FNLCR – “Nanoscale 3-D imaging of cells and tissue by FIB-SEM” Stephen Hughes. Ph.D., Retroviral Replication Laboratory, NCI, CCR – “Small Molecule Inhibitors of Drug Resistant Forms of HIV-1 Integrase” – E-093-2013
10:45 – 11:00 AM	Break and Poster Session
11:00 AM – 12:00 PM	Technology Session Two MODERATOR: Richard Griffin, AICP, CEcD, Director, The City of Frederick, Department of Economic Development Raj Chari, Ph.D., Genome Modification Core, FNLCR – “Gene Editing in Cancer Research” Bruce Shapiro, Ph.D., RNA Biology Laboratory, NCI, CCR – “RNA Nanoparticle Technologies for Use in Developing Cancer Therapeutics” (“Nucleic Acid Nanoparticles for Triggering RNA Interference” ) – E-156-2014 Josip Blonder, M.D., Antibody Characterization Laboratory, Cancer Research Technology Program, FNLCR – “Renal Carcinoma Biomarkers” E-317-2008 Jennifer Clare Jones, M.D., Ph.D., Vaccine Branch, NCI, CCR – "New Technologies for the Analysis of Exosomes in Precision Medicine"
12:00 – 12:20 PM	Technology Ambassador Poster Pitches
12:20 – 1:30 PM	Lunch / Networking / Poster Session
1:30 – 2:15 PM	Success Story Roundtable MODERATOR: Tom Stackhouse, Ph.D., NCI TTC Jon Kiburz, JD, MBA, Director, Partnering & Strategy – MedImmune Anthony D. Saleh, Ph.D., CEO – miRecule, Inc. Jeff Strovel, Ph.D., President and CEO – Veralox Therapeutics, LLC
2:15 – 3:30 PM	Technology Session Three MODERATOR: Ron Kaese, Director, Federal Programs. Maryland Technology Development Corporation (TEDCO) William Douglas Figg, Ph.D., NCI, CCR, Genitourinary Malignancies Branch – “Thalidomide Analogs that Inhibit Inflammation and Angiogenesis” – E-208-2015 Beverly Mock, Ph.D., Laboratory of Cancer Biology and Genetics, NCI, CCR – “Methods for Selection of Cancer Patients and Predicting Efficacy of Combination Therapy” – E-013-2012 Stephen Adler, Ph.D., NCI Molecular Imaging Program, FNLCR – “Micro-Dose Calibrator for Pre-clinical Radiotracer Assays” – E-241-2016 Ludmila Prokunina-Olsson, Ph.D., Division of Cancer Epidemiology and Genetics, Laboratory of Translational Genomics – “Therapeutic Developments Based on Interferon Lambda 4 (IFNL4) – E-217-2011 Matt Holderfield, Ph.D., RAS Drug Discovery Group, FNLCR – “New Weapons to Penetrate the Armor: Tools Developed at the NCI RAS Initiative to Enable Discovery of RAS Therapeutics”
3:30 – 3:45 PM	Break and Poster Session
3:45 – 4:45 PM	Technology Session Four MODERATOR: Heather Gramm, Frederick County Department of Economic Development David Calabrese, Ph.D., Chemical Biology Laboratory, NCI, CCR – “Small Molecule Anti-cancer Agents that Stabilize the MYC-G-Quadruplex” – E-053-2015 Chris Buck, Ph.D., Laboratory of Cellular Oncology, NCI, CCR – “A Vaccine Against Polymavirus-Induced Kidney Disease” – E-168-2011 Don Bottaro, Ph.D., Urologic Oncology Branch, NCI, CCR – “A Novel Platform for Growth Factor Antagonist Development” – E-230-2011 Uma Mudunuri, Ph.D., Advanced Biomedical Computing Center, FNLCR –“Solutions for Integration, Access and Visualization of Large Scale Scientific Data” (FNLCR technology / capability) Mitchell Ho, Ph.D., Laboratory of Molecular Biology, NCI, CCR – “High-Affinity Rabbit Monoclonal Antibodies for Cancer Treatment” – E-198-2012
4:45 – 5:00 PM	Closing Remarks Jim Pannucci, Ph.D., Director Partnership Development Office, FNLCR
5:00 – 7:00 PM	Networking Event (adjacent to ATRF)

Special Poster Session

Representatives from the NCI Technology Transfer Ambassadors Program (TTAP) will present the following posters highlighting technologies available for licensing and/or partnering:

Presented by NCI TTAP Ambassador, Jyoti Roy, Ph.D.
Mitchell Ho, Ph.D., Laboratory of Molecular Biology, NCI, CCR – “Human Monoclonal Antibodies Targeting Glypican-2 in Neuroblastoma” – E-090-2013
Presented by NCI TTAP Ambassador, Kazi Rahman, Ph.D.
James P. Mitchell, Ph.D., Radiation Biology Branch, NCI, CCR – “Video Monitoring and Analysis System for Vivarium Cage Racks” – E-090-2013
Presented by NCI TTAP Ambassador, Nellie Moshkovich, Ph.D.
Rimas Orentas, Ph.D., formerly with Pediatric Oncology Branch and Chris Chien, Ph.D. – “Immunotherapeutics for Pediatric Solid Tumors” – E-007-2014
Presented by NCI TTAP Ambassador, Jennifer Cowan, Ph.D.
De Yang, M.D., Ph.D., Cancer and Inflammation Program, NCI, CCR – “HMGN Polypeptides as Immune Enhancers and HMGN Antagonists as Immune Suppressants” – E-185-2008
Presented by NCI TTAP Ambassador, Jon Nye, Ph.D.
Terry Fry, M.D., Pediatric Oncology Branch and Chris Chien, Ph.D. – “Chimeric Antigen Receptors for the Treatment of Leukemia and Other Cancers” – E-133-2016
Presented by NCI TTAP Ambassador, Delphine Lissa, Ph.D.
Jeffrey Baron, M.D., Eunice Kennedy Shriver National Institute of Childhood Health and Human Development (NICHD) – “Diagnostic Assays for the Detection of Thyroid Cancer” – E-016-2013
Presented by NCI TTAP Ambassador, Sarwat Naz, Ph.D.
Lauren Wood, M.D., Vaccine Branch, NCI, CCR – “Multivalent Immunogenic Peptides (Vaccines) for the Treatment of Prostate and Breast Cancer” – E-047-2014
Presented by NCI TTAP Ambassador, Tao Liu, Ph.D.
Bradford Wood, M.D., NIH Center for Interventional Oncology, NCI, CCR – “Implantable Medical Devices with Electric Current Retrieval Assist" – E-088-2014
Presented by NCI TTAP Ambassador, Kyster Nanan, Ph.D.
Stanislaw Kaczmarczyk, Ph.D. and Deb Chatterjee, Ph.D., Protein Expression Laboratory, NCI, CCR – “Cancer Immunotherapy Using Virus-like Particles” – E-050-2014
Presented by NCI TTAP Ambassador, Rebecca Erwin-Cohen, Ph.D.,
Anu Puri, Ph.D. RNA Biology Laboratory, NCI, CCR – “Photoactivatable Lipid-based Nanoparticles as a Vehicle for Dual Agent Delivery” – E-482-2013
Prepared by NCI TTAP Ambassador, Ananda Chowdhury, Ph.D.; presented by Taryn Dick, Ph.D., NCI TTC and David Calabrese, Ph.D., Chemical Biology Laboratory
John Schneekloth, Ph.D. Chemical Biology Laboratory and Beverly Mock, Ph.D., Laboratory of Cancer Biology and Genetics, NCI, CCR –
“MYC-G-Quadruplex Stabilizing Small Molecules and Their Use” – E-053-2015
Prepared by NCI TTAP Ambassador, David Wei, Ph.D.
Martin Schnermann, Ph.D., Chemical Biology Laboratory, NCI, CCR – “Near-IR Light-cleavable Conjugates and Conjugate Precursors” – E-245-2016

An additional poster will be presented by:

13. Ken Miller, M.S., Project Manager, Center for Advanced Preclinical Research (CAPR), NCI, CCR and Leidos Biomedical Research Inc., LASP - “Preclinical Evaluation of Therapeutic Compounds in Mouse Models for Cancer at the Center for Advanced Preclinical Research (CAPR)”

Who Attended:

Life-science / healthcare companies
Investors
Entrepreneurs
Researchers
Technology scouts looking to commercialize technologies
Professional services firms
Educators
All interested stakeholders

Updated

Thursday, April 11, 2019

You are here